Five things to know:
1. Quarterly net sales grew 5% year-over-year, according to a news release.
2. Knee sales were $706.3 million, a 7.5% increase year-over-year.
3. Hip sales fell 0.6% year-over-year with $465.3 million.
4. Sports medicine, extremities, trauma, craniomaxillofacial and thoracic sales rose 3.3% year-over-year with $423.2 million.
5. Zimmer Biomet is raising its full-year guidance and expects 2023 revenue to increase 6.5% to 7% compared to 2022 sales.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
